Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) EBT: 2018-2024

Historic EBT for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $204.0 million.

  • CureVac N.V's EBT rose 11.52% to -$67.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $243.5 million, marking a year-over-year increase of 181.54%. This contributed to the annual value of $204.0 million for FY2024, which is 172.92% up from last year.
  • CureVac N.V's EBT amounted to $204.0 million in FY2024, which was up 172.92% from -$279.7 million recorded in FY2023.
  • CureVac N.V's 5-year EBT high stood at $204.0 million for FY2024, and its period low was -$471.9 million during FY2021.
  • Its 3-year average for EBT is -$110.0 million, with a median of -$254.2 million in 2022.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 204.80% in 2021, then soared by 172.92% in 2024.
  • Over the past 5 years, CureVac N.V's EBT (Yearly) stood at -$154.8 million in 2020, then plummeted by 204.80% to -$471.9 million in 2021, then spiked by 46.13% to -$254.2 million in 2022, then fell by 10.04% to -$279.7 million in 2023, then skyrocketed by 172.92% to $204.0 million in 2024.